Plain-English translation of NCT06566482 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether dexmedetomidine-esketamine, a combination of two medications, can help you sleep better and control pain safely after surgery โ especially if you're at high risk for obstructive sleep apnea (a condition where your airway narrows during sleep). The medication is designed to work differently than standard pain relievers, by promoting natural sleep and reducing pain without the breathing risks that come with opioids alone.
After surgery, patients at high risk for sleep apnea face a real challenge: they need pain relief, but standard pain medications can actually make their breathing problems worse and keep them from sleeping well. This trial is testing whether this new medication combination can break that cycle by providing safe pain control while helping the body sleep naturally.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive surgery as planned, and afterward you'll receive either the new medication combination or a standard pain medication through a patient-controlled pump that lets you give yourself doses when you need pain relief. You'll use this pump for 24 to 48 hours after surgery while doctors monitor your sleep quality, breathing, and pain levels. The study team will track how well you sleep and how well your pain is controlled during your hospital stay.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
China